WPC
BIIB icon

Wedmont Private Capital’s Biogen BIIB Stock Holding History

Wedmont Private Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$757K Buy
3,467
+455
+15% +$96.5K 0.02% 468
2026
Q2 		$600K Buy
3,012
+104
+4% +$19.9K 0.02% 495
2026
Q1 		$523K Buy
2,908
+115
+4% +$21.2K 0.02% 480
2025
Q4 		$522K Buy
2,793
+113
+4% +$18.5K 0.02% 454
2025
Q3 		$408K Buy
2,680
+490
+22% +$66.2K 0.02% 526
2025
Q2 		$291K Buy
2,190
+81
+4% +$10.1K 0.01% 582
2025
Q1 		$243K Sell
2,109
-1,561
-43% -$223K 0.01% 579
2024
Q4 		$546K Buy
3,670
+2,392
+187% +$403K 0.03% 352
2024
Q3 		$234K Sell
1,278
-1,373
-52% -$287K 0.01% 586
2024
Q2 		$610K Buy
2,651
+238
+10% +$51.7K 0.04% 298
2024
Q1 		$498K Buy
2,413
+446
+23% +$104K 0.04% 320
2023
Q4 		$507K Buy
1,967
+743
+61% +$182K 0.04% 301
2023
Q3 		$323K Buy
1,224
+47
+4% +$12.6K 0.03% 355
2023
Q2 		$328K Buy
1,177
+142
+14% +$42.3K 0.04% 359
2023
Q1 		$293K Sell
1,035
-128
-11% -$35.4K 0.04% 355
2022
Q4 		$325K Buy
1,163
+253
+28% +$71.5K 0.05% 317
2022
Q3 		$243K Buy
+910
New +$193K 0.05% 312

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return

Wedmont Private Capital's BIIB Position: Q3 2026 in Review

Wedmont Private Capital increased its Biogen (BIIB) stake by 15% in Q3 2026, buying an estimated $96.5K and bringing the position to 3,467 shares worth $757K. The position accounts for 0.02% of the portfolio, ranked #468.

Wedmont Private Capital first reported a position in BIIB in Q3 2022 and has held it in 17 quarters since. 41 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Wedmont Private Capital held 3,467 shares of Biogen worth $757K as of Q3 2026.
  • Wedmont Private Capital bought 455 Biogen shares in Q3 2026, an estimated $96.5K.
  • Biogen made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #468 holding.
  • Wedmont Private Capital first reported a position in Biogen in Q3 2022 and has held it in 17 quarters since.
  • 41 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.